For the first time, it was discovered in the United States that a pharmaceutical company that caused the opioid health crisis was in the courtroom. The U.S. division of the Israeli company Teva Pharmaceuticals has deliberately underestimated the potential risks of commercially available painkillers and has not taken adequate measures to prevent their spread, according to the Arbitration Tribunal, which has been in New York since June. Population in the state of New York.
The Opioids Medications used for pain management. They began to compile in the early twentieth century, but their greatest spread dates back to the nineties. At that time, the American pharmaceutical company Burdock began selling oxycodone, marketed as OxyContin, and launched a very serious marketing campaign to persuade physicians to prescribe it to their patients, claiming that it could be used to treat chronic pain without a problem. In the United States, many physicians misuse oxycodone drugs, and in many cases patients begin to prolong their intake beyond the prescribed doses: but both oxycodone and other opioids cause serious drug problems and cause hundreds of thousands more deaths. People for the last 20 years.
However, Burdock was not the only pharmaceutical company to play a role in the spread of opioids. Teva Pharmaceuticals, like other pharmaceutical companies, has been involved in many of the thousands of cases related to the opioid addiction epidemic in the United States.
The ruling in New York is the second (last month, in Ohio, another ruling recognizing the responsibility of large-scale distribution chains CVS, Walgreens and Walmart) and two pharmaceutical companies. And the large-scale supply chain that sells them. In the coming months, compensation to be paid by Deva and other responsible companies will be established.
This test is particularly relevant to the opioid-related crisis in Nassau and Suffolk districts. Between 2010 and 2018, the number of opioid deaths in both districts doubled to more than 1,600, respectively, according to data from the Centers for Disease Control and Prevention, America’s most important public health control body. 3,000 in 2019. According to the arbitral tribunal, the New York State Government was also partly responsible for contributing to the crisis because it should have regulated the circulation of goods more strictly.
Shortly before the trial began, Johnson & Johnson Pharmaceuticals announced the payment $ 230 million To the State of New York as part of an agreement to resolve its legal conflicts related to the opioid crisis. A few weeks later, Cardinal Health, McKesson Corp, and Amerisource Bergen, three major opioid distributors in the United States, sued New York State. More than $ 1 billion.
However, a year ago, Burdock – who ended up in bankruptcy in 2019 – pleaded guilty to a charge in a deal with the US judiciary, which established that he was fined $ 8 billion and fined $ 225 million and had no manager. The partner of the company will go to jail. On December 17, a court declared the settlement illegal, but Burdock is expected to appeal.